Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Dec 1, 2025

Accession no.
0001106578-25-000035
Filed
Dec 1, 2025
Trade date
Nov 26-28, 2025
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 9 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.89M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (Chairperson & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 26, 2025Common StockMOption exerciseAcquired+4,000$120.26+$481,0404,130Direct
Nov 26, 2025Common StockSSaleDisposed−2,134$484.45F2−$1,033,816.31,996Direct
Nov 26, 2025Common StockSSaleDisposed−1,366$485.24F3−$662,837.84630Direct
Nov 26, 2025Common StockSSaleDisposed−500$487.10−$243,550130Direct
Nov 28, 2025Common StockMOption exerciseAcquired+4,000$120.26+$481,0404,130Direct
Nov 28, 2025Common StockSSaleDisposed−800$485.71F4−$388,5683,330Direct
Nov 28, 2025Common StockSSaleDisposed−1,609$487.30F5−$784,065.71,721Direct
Nov 28, 2025Common StockSSaleDisposed−1,091$488.36F6−$532,800.76630Direct
Nov 28, 2025Common StockSSaleDisposed−500$490.25−$245,125130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 26, 2025Common StockMOption exerciseDisposed−4,000$0.00$062,000Direct
Nov 28, 2025Common StockMOption exerciseDisposed−4,000$0.00$058,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $484.04 to $485.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $485.11 to $485.395. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $485.71 to $485.715. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $487.00 to $487.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $488.005 to $488.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)